Uli Frevert

Uli Frevert is an experienced leader in clinical development and translational medicine, currently serving as Head of Translational Clinical Trials and Vice President of Translational Medicine at Moderna since July 2022. Prior roles include Executive Director at CSL Behring, overseeing global product leadership in immunology, and leadership positions at The Janssen Pharmaceutical Companies, Covance, and Bristol-Myers Squibb, focusing on early clinical development and cardiovascular/metabolic research. Uli Frevert has a strong background in clinical pharmacology from Novartis and drug discovery leadership at Abbott Laboratories. Early career experiences include a postdoctoral fellowship at Harvard Medical School and medical training at Medical University Hannover. Uli Frevert holds a Dr. med. degree and is a licensed physician in Germany.